IntriCon (IntriCon) Cash And Cash Equivalents : $5.3 Mil (As of Mar. 2022)

View and export this data going back to 1968. Start your Free Trial

What is IntriCon Cash And Cash Equivalents?

IntriCon's quarterly cash and cash equivalents declined from Sep. 2021 ($13.02 Mil) to Dec. 2021 ($5.58 Mil) but then stayed the same from Dec. 2021 ($5.58 Mil) to Mar. 2022 ($5.31 Mil).

IntriCon's annual cash and cash equivalents increased from Dec. 2019 ($8.52 Mil) to Dec. 2020 ($8.61 Mil) but then declined from Dec. 2020 ($8.61 Mil) to Dec. 2021 ($5.58 Mil).

IntriCon Cash And Cash Equivalents Historical Data

The historical data trend for IntriCon's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntriCon Cash And Cash Equivalents Chart

IntriCon Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Cash And Cash Equivalents

Get a 7-Day Free Trial

1.02

8.05

8.52

8.61

5.58

IntriCon Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Cash And Cash Equivalents	Get a 7-Day Free Trial															11.76	6.08	13.02	5.58	5.31

IntriCon Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

IntriCon (NAS:IIN) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

IntriCon Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of IntriCon's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

IntriCon (IntriCon) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IntriCon Corp (NAS:IIN) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

1260 Red Fox Road, Arden Hills, MN, USA, 55112

Website

https://www.intricon.com

IntriCon Corp is an international company and joint development manufacturer (JDM) of micromedical components, sub-assemblies and final devices. The company serves as a JDM partner to medical device original equipment manufacturers by designing, developing, engineering, manufacturing, packaging and distributing micromedical products for high growth markets, such as diabetes, peripheral vascular, interventional pulmonology, electrophysiology and hearing healthcare. It manufactures microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components and complete body-worn devices for leading and emerging medical device manufacturers.

Executives

Annalee Lutgen	officer: Interim CFO	C/O INTRICON CORPORATION 1260 RED FOX ROAD ARDEN HILLS MN 55112
Michael Geraci	officer: Vice President, Sales	1260 RED FOX ROAD ARDEN HILLS MN 55112
Dennis Gonsior	officer: Vice Pres., Global Operations	1260 RED FOX ROAD ARDEN HILLS MN 55112
Kathleen P. Pepski	director	3100 EAST HENNEPIN AVENUE, MINNEAPOLIS MN 55413
Ellen Scipta	officer: CFO	C/O INTRICON CORPORATION, 1260 RED FOX ROAD, ARDEN HILLS MN 55112
Heather D. Rider	director	C/O INOGEN, INC., 326 BOLLAY DRIVE, GOLETA CA 93117
Raymond Huggenberger	director	326 BOLLAY DRIVE, GOLETA CA 93117
Greg Gruenhagen	officer: VP, Corp. Qlty. & Reg. Affairs	C/O INTRICON CORPORATION 1260 RED FOX ROAD ARDEN HILLS MN 55112
Philip Irving Smith	director	4503 BROWNDALE AVENUE, EDINA MN 55424
Scott Longval	officer: Chief Financial Officer	1260 RED FOX ROAD ARDEN HILLS MN 55112
Mark Stephen Gorder	director, officer: President & CEO	1260 RED FOX RD ARDEN HILLS MN 55112
Steven Binnix	officer: Vice President-RTI Electronics	1260 RED FOX ROAD ARDEN HILLS MN 55112
Michael J Mckenna	director	8650 S OCEAN DRIVE APT 701 JENSEN BEACH FL 34957
Robert N Masucci	director	1406 GRASSHOPPER LANE GWYNEDD VALLEY PA 19437
Philip N Seamon	director	1260 RED FOX ROAD ARDEN HILLS MN 55112